Showing 1 - 1 results of 1 for search 'Egon Pfarr', query time: 0.01s Refine Results
  1. 1
    Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease

    Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease by Odette S Reifsnider, Anuraag R Kansal, Pranav K Gandhi, Lael Cragin, Sarah B Brand, Egon Pfarr, Kyle Fahrbach, Anastasia Ustyugova

    Published 2021-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: